{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:21:16Z","timestamp":1793146876944,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.heliyon.2023.e20110","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T12:30:20Z","timestamp":1694867420000},"page":"e20110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The effect of elexacaftor\/tezacaftor\/ivacaftor on non-pulmonary symptoms in adults with cystic fibrosis"],"prefix":"10.1016","volume":"9","author":[{"given":"Sarah","family":"Allgood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-3065","authenticated-orcid":false,"given":"Reena","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Bubaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6892-3512","authenticated-orcid":false,"given":"Kristin","family":"Riekert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8529-0585","authenticated-orcid":false,"given":"Kevin J.","family":"Psoter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9088-8749","authenticated-orcid":false,"given":"Noah","family":"Lechtzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e20110_bib1","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.chest.2021.06.017","article-title":"Pulmonary complications in cystic fibrosis: past, present, and future: adult cystic fibrosis series","volume":"160","author":"Mingora","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.heliyon.2023.e20110_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis","volume":"361","author":"Ratjen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e20110_bib3","series-title":"Cystic Fibrosis Foundation Patient Registry 2017 Annual Report","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e20110_bib4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jpainsymman.2016.03.023","article-title":"The association between pain and clinical outcomes in adolescents with cystic fibrosis","volume":"52","author":"Lechtzin","year":"2016","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.heliyon.2023.e20110_bib5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pmn.2017.11.011","article-title":"Descriptions of the pain experience in adults and adolescents with cystic fibrosis","volume":"19","author":"Allgood","year":"2018","journal-title":"Pain Manag. Nurs."},{"key":"10.1016\/j.heliyon.2023.e20110_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jcf.2018.03.003","article-title":"Prevalence of severe fatigue among adults with cystic fibrosis: a single center study","volume":"17","author":"Nap-van der Vlist","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2023.e20110_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0091-6749(92)90183-3","article-title":"Impact of sinusitis in cystic fibrosis","volume":"90","author":"Ramsey","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2023.e20110_bib8","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s10620-015-3546-7","article-title":"Gastrointestinal manifestations of cystic fibrosis","volume":"60","author":"Kelly","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.heliyon.2023.e20110_bib9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/thoraxjnl-2014-205983","article-title":"Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of the International Depression Epidemiological Study across nine countries","volume":"69","author":"Quittner","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.heliyon.2023.e20110_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/thoraxjnl-2015-207488","article-title":"International committee on mental health in cystic fibrosis: cystic fibrosis foundation and European cystic fibrosis society consensus statements for screening and treating depression and anxiety","volume":"71","author":"Quittner","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.heliyon.2023.e20110_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2020.101279","article-title":"Sleep disorders in cystic fibrosis: a systematic review and meta-analysis","volume":"51","author":"Reiter","year":"2020","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.heliyon.2023.e20110_bib12","first-page":"5","article-title":"Elexacaftor\/tezacaftor\/ivacaftor (Trikafta) for cystic fibrosis","volume":"62","year":"2020","journal-title":"Med. Lett. Drugs Ther."},{"key":"10.1016\/j.heliyon.2023.e20110_bib13","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e20110_bib14","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e20110_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jcf.2021.02.003","article-title":"PROMISE: working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy","volume":"20","author":"Nichols","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2023.e20110_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.psym.2017.04.001","article-title":"Cystic fibrosis transmembrane regulator modulators: implications for the management of depression and anxiety in cystic fibrosis","volume":"58","author":"Talwalkar","year":"2017","journal-title":"Psychosomatics"},{"key":"10.1016\/j.heliyon.2023.e20110_bib17","article-title":"Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators","author":"Konrad","year":"2020","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.heliyon.2023.e20110_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1015276414526","article-title":"Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening","volume":"11","author":"Cella","year":"2002","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.heliyon.2023.e20110_bib19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item sinonasal outcome test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.heliyon.2023.e20110_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejpain.2005.03.008","article-title":"Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain","volume":"10","author":"Slappendel","year":"2006","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.heliyon.2023.e20110_bib21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/003655299750025327","article-title":"Psychometric validation of a constipation symptom assessment questionnaire","volume":"34","author":"Frank","year":"1999","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e20110_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.genhosppsych.2010.03.006","article-title":"The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review","volume":"32","author":"Kroenke","year":"2010","journal-title":"Gen. Hosp. Psychiatr."},{"key":"10.1016\/j.heliyon.2023.e20110_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.heliyon.2023.e20110_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10010023","article-title":"Real-world safety of CFTR modulators in the treatment of cystic fibrosis: a systematic review","volume":"10","author":"Dagenais","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.heliyon.2023.e20110_bib25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/alr.22251","article-title":"Ivacaftor improves rhinologic, psychologic, and sleep-related quality of life in G551D cystic fibrosis patients","volume":"9","author":"McCormick","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.heliyon.2023.e20110_bib26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jcf.2020.07.002","article-title":"Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis","volume":"20","author":"DiMango","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2023.e20110_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s00405-023-07859-4","article-title":"Effects of CFTR-modulator triple therapy on sinunasal symptoms in children and adults with cystic fibrosis","author":"Bode","year":"2023","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"10.1016\/j.heliyon.2023.e20110_bib28","article-title":"Satisfaction and effectiveness of opioid pain management among adults with cystic fibrosis: a mixed methods study","author":"Allgood","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2023.e20110_bib29","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1038\/ctg.2017.10","article-title":"Impact of CFTR modulation on intestinal pH, motility, and clinical outcomes in patients with cystic fibrosis and the G551D mutation","volume":"8","author":"Gelfond","year":"2017","journal-title":"Clin. Transl. Gastroenterol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023073188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023073188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:58:28Z","timestamp":1784926708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023073188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2405844023073188"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20110","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of elexacaftor\/tezacaftor\/ivacaftor on non-pulmonary symptoms in adults with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e20110"}}